In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 0.1 | 10.3 | 0.0 | 0.0 |
Revenue growth | -99.0% | 33703.9% | | |
Cost of goods sold | 0.1 | 8.9 | 0.0 | 0.0 |
Gross profit | 0.0 | 1.4 | 0.0 | 0.0 |
Gross margin | 25.8% | 13.6% | 0.0% | |
Selling, general and administrative | 23.0 | 7.9 | 5.7 | 5.6 |
Research and development | 5.0 | 0.9 | 0.2 | |
General and administrative | 22.7 | 7.9 | 5.7 | |
EBITA | -27.3 | -8.9 | -5.9 | -5.6 |
EBITA margin | -26018.2% | -86.4% | -19336.0% | |
Amortization of intangibles | 0.1 | | | |
EBIT | -27.4 | -8.9 | -5.9 | -5.6 |
EBIT margin | -26120.0% | -86.4% | -19336.0% | |
Pre-tax income | -46.4 | -9.1 | -5.8 | -5.7 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
Earnings from continuing ops | -46.4 | -9.1 | -5.8 | -5.7 |
Earnings from discontinued ops | 10.9 | 3.7 | | |
Net income | -46.4 | -9.1 | -5.8 | -5.7 |
Net margin | -44148.9% | -89.1% | -19194.2% | |
|
Diluted EPS | ($2.43) | ($1.33) | ($1.52) | ($1.57) |
Shares outstanding (diluted) | 19.1 | 6.9 | 3.8 | 3.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |